The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
April 25th 2025
New research reveals how high blood sugar from type 2 diabetes alters brain function, mimicking early Alzheimer symptoms and impacting memory.
Antibiotic Use in Infants May Increase Risk of Inflammatory Bowel Disease Later in Life
July 31st 2020According to a study published in Genome Medicine, the disruption of gut bacteria through the use of antibiotics soon after birth has the ability to affect the immune system’s process of maturation.
Read More
Tip of the Week: HIPAA Intertwines with Myriad Aspects of Practice
July 29th 2020Practicing according to HIPAA standards, though, is not just to protect yourself legally, but it is the right thing to do by way of patient care, particularly through the ethical tenets of beneficence and patient autonomy.
Read More
Telehealth Could Have Long-Lasting, Unforeseen Effect on Health Care After COVID-19
July 29th 2020Although the rapid expansion of telehealth has been an essential part of keeping patients safe during the COVID-19 pandemic, the potential long-term effects of this expansion have not been fully understood.
Read More
Pharmacists Express Concern Over Lack of Provider Status in Proposed Stimulus Package
July 28th 2020As legislators debate the next stimulus package, pharmacists are expressing dismay that the current language does not include designating pharmacists as providers under Medicare Part B for COVID-19 testing and immunization.
Read More
Ibuprofen Injection Demonstrates Significant Reduction of Opioid Use in Orthopedic Trauma Patients
July 28th 2020The results of a level 1 trauma center study have shown that ibuprofen injection (Caldolor, Cumberland Pharmaceuticals) significantly reduces the quantity of opioids required to manage pain after a traumatic injury with fracture.
Read More
FDA Approves Budesonide/Glycopyrrolate/Formoterol Fumarate for Treatment of Patients With COPD
July 24th 2020Budesonide/glycopyrrolate/formoterol fumarate (Breztri Aerosphere, AstraZeneca) has been approved by the FDA for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD), according to a press release.
Read More
CDC Update: Duration of Isolation, Precautions for Adults with COVID-19
July 24th 2020The latest update from the CDC incorporates evidence that informs the duration of isolation and precautions recommended to prevent transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to others while limiting unnecessary prolonged isolation and unnecessary use of laboratory testing resources.
Read More